Cologne, Germany

Michael Stroehlein


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Cologne, DE (2017)
  • Köln, DE (2017)

Company Filing History:


Years Active: 2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Michael Stroehlein

Introduction

Michael Stroehlein is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of medical technology, particularly in cancer treatment. With a total of two patents to his name, Stroehlein's work focuses on improving therapeutic outcomes for patients undergoing immune therapy.

Latest Patents

Stroehlein's latest patents include a method for predicting an improved therapeutic benefit for individuals with tumor loads before initiating immune therapy. This invention relates to pharmaceutical compositions that activate immune cells against tumors. His second patent involves a method for the removal of tumor cells from intraoperatively collected blood salvage. This ex vivo method utilizes antibodies and scaffold proteins that mimic antibodies, allowing for the purification of blood salvage for reinfusion to patients.

Career Highlights

Throughout his career, Stroehlein has worked with various companies, including Horst Lindhofer. His innovative approaches have garnered attention in the medical community, particularly for their potential to enhance patient care.

Collaborations

Stroehlein has collaborated with notable individuals such as Horst Lindhofer and Markus M Heiss. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Michael Stroehlein's contributions to medical technology through his patents demonstrate his commitment to improving cancer treatment. His innovative methods have the potential to significantly impact patient outcomes in the field of immune therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…